Summary
Cardiac progenitor stem cell (CPC) therapy for myocardial infarction (MI) has been shown to elicit moderate beneficial effects. Research currently focuses on improving CPC administration, retention, and efficacy. The conducted project work achieved the development of Magnetic...
More information & hyperlinks
Web resources: | http://lbi-cy.com/ |